CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

Otros idiomas CK Life Sciences Int'l., (Holdings) Inc.

Acciones

775 KYG2176J1058

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:08:06 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,375 ^HKD	+2,74 %		+10,29 %	-39,52 %

05/04	CK Life Sciences presentará los datos preclínicos de dos vacunas contra el cáncer; las acciones suben un 11	MT
19/03	CK Life Sciences Int'l., (Holdings) Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11%	05/04
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models Using AI and Biomarker Data	06/11
CK Life Sciences to Present Preclinical Study of Cancer Vaccines at US Immunotherapy Conference	01/11
Ck Life Sciences Int'l., Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1	01/11
CK Life Sciences International's Profit Slumps 43% in H1; Shares Down 3%	16/08/23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	01/08/23
CK Life Sciences Int'l., Inc. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payment Date 05 June 2023	14/03/23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development opening a new paradigm for scientific innovation	28/11/22
XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation	25/11/22
CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee	01/09/22
CK Life Sciences' H1 Profit Down 35%	03/08/22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	02/08/22
CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each	26/07/22
CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended 31 December 2021, Payable on 01 June 2022	15/03/22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/03/22
CK Life Sciences Int'l., Inc. acquired Gale Road vineyard.	15/03/22
CK Hutchison : CK Asset profits rise in H1	05/08/21
CK Life Sciences 'l : Posts Higher Profit, Revenue in H1	04/08/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas CK Life Sciences Int'l., (Holdings) Inc.

Acciones

775

KYG2176J1058

Otros idiomas

Filtros